The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer

被引：0

作者：

Jordane Divoux

Romane Florent

Margaux Jacobs

Justine Lequesne

Jean-Michel Grellard

Chankannira San

Sara Grossi

Katia Kerdja

Bénédicte Clarisse

Gwenaelle Boudier

François Cherifi

Mélanie Briand

Enora Dolivet

Alisson Johnson

Brice Dubois

Valentin Harter

Joëlle Lacroix

Charlotte Raboutet

Brigitte Marie

Nathalie Rousseau

Cécile Blanc-Fournier

Dominique Vaur

Martin Figeac

Laurent Poulain

Louis-Bastien Weiswald

George Emile

机构：

[1] Université de Caen Normandie,INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers)

[2] UNICANCER,Comprehensive Cancer Center François Baclesse

[3] Université de Caen Normandie,US PLATON, ORGAPRED Core Facility

[4] UNICANCER,Comprehensive Cancer Center François Baclesse, Breast Cancer Unit

[5] Institut Normand du Sein,Comprehensive Cancer Center François Baclesse, Clinical Research Department

[6] UNICANCER,US PLATON, Biological Resource Center ‘OvaRessources’

[7] Université de Caen Normandie,Comprehensive Cancer Center François Baclesse, Department of Surgery

[8] UNICANCER,Comprehensive Cancer Center François Baclesse, North

[9] UNICANCER,West Canceropole Data Center

[10] UNICANCER,Comprehensive Cancer Center François Baclesse, Department of Radiology

[11] IRCBN Institut Régional du Cancer Basse Normandie,Biological Resource Center ‘Tumorotheque de Caen Basse

[12] UNICANCER,Normandie’

[13] UNICANCER,Comprehensive Cancer Center François Baclesse, Department of Biopathology

[14] University of Lille,Comprehensive Cancer Center François Baclesse, Department of Cancer Biology and Genetics

[15] Comprehensive Cancer Center François Baclesse,CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41

[16] Comprehensive Cancer Center François Baclesse, UAR 2014

来源：

BMC Cancer | / 23卷 / 1期

关键词：

Triple negative breast cancer; Patient-derived tumor organoids; Predictive functional assays; Chemo-immunotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer
Divoux, Jordane
Florent, Romane
Jacobs, Margaux
Lequesne, Justine
Grellard, Jean-Michel
San, Chankannira
Grossi, Sara
Kerdja, Katia
Clarisse, Benedicte
Boudier, Gwenaelle
Cherifi, Francois
Briand, Melanie
Dolivet, Enora
Johnson, Alisson
Dubois, Brice
Harter, Valentin
Lacroix, Joelle
Raboutet, Charlotte
Marie, Brigitte
Rousseau, Nathalie
Blanc-Fournier, Cecile
Vaur, Dominique
Figeac, Martin
Poulain, Laurent
Weiswald, Louis-Bastien
Emile, George
[J]. BMC CANCER, 2023, 23 (01)
[2] The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
Psilopatis, Iason
Mantzari, Amalia
Vrettou, Kleio
Theocharis, Stamatios
[J]. BIOMEDICINES, 2023, 11 (03)
[3] Bladder cancer: Patient-derived organoids as a tool for precision medicine
Minoli, M.
Kiener, M.
Federizzi, T.
Gasperini, P.
Demichelis, F.
Thalmann, G. N.
Seiler-Blarer, R.
Kruithof-De Julio, M.
[J]. EUROPEAN UROLOGY, 2021, 79 : S637 - S637
[4] BLADDER CANCER: PATIENT-DERIVED ORGANOIDS AS A TOOL FOR PRECISION MEDICINE
Minoli, Martina
Kiener, Mirjam
Fedrizzi, Tarcisio
Gasperini, Paola
Demichelis, Francesca
Thalmann, George Niklaus
Seiler-Blarer, Roland
Kruithof-de Julio, Marianna
[J]. JOURNAL OF UROLOGY, 2021, 206 : E1135 - E1136
[5] Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics
Bhatia, Sonam
Kramer, Melissa
Russo, Suzanne
Naik, Payal
Arun, Gayatri
Brophy, Kyle
Andrews, Peter
Fan, Cheng
Perou, Charles M.
Preall, Jonathan
Ha, Taehoon
Plenker, Dennis
Tuveson, David A.
Rishi, Arvind
Wilkinson, John E.
McCombie, W. Richard
Kostroff, Karen
Spector, David L.
[J]. CANCER RESEARCH, 2022, 82 (07) : 1174 - 1192
[6] The adaptive resistome in triple-negative breast cancer: Functional targeting in patient-derived organoids and cell lines
Classen, S.
Rahlf, E.
Goerte, J.
Parplys, A. C.
Schumacher, U.
Petersen, C.
Rothkamm, K.
Toulany, M.
Cordes, N.
Borgmann, K.
[J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S195 - S195
[7] Patient derived organoids as a tool for use of precision medicine in bladder cancer
Thomas, Patrick
Saadat, Paria
Williams, Elizabeth
Vela, Ian
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 62 - 62
[8] Ovarian cancer patient-derived organoids and tumor xenografts as preclinical models for precision medicine
Yu, Yebeen
Park, Hye Ju
Kang, Cha Yeon
Lim, Myong Cheol
Park, Sang Yoon
Woo, Yo Han
Kim, Yun-Hee
Kong, Sun-Young
[J]. CANCER RESEARCH, 2023, 83 (07)
[9] Utilizing decellularized triple-negative breast cancer patient-derived tumor models as drug testing platforms
Wright, Maryl
Khoa Nguyen
Martin, Elizabeth
Bratton, Melyssa
Collins-Burow, Bridgette
Burow, Matthew
[J]. CANCER RESEARCH, 2022, 82 (12)
[10] Pancreatic cancer patient-derived organoids as a tool for personalized medicine
Tiriac, Herve
[J]. CANCER RESEARCH, 2020, 80 (16)

← 1 2 3 4 5 →